Pvmed Raises Us $14 Million Series A Funding From Cherami, Philips, Jhf, Cococapital, And Strategy Capital
Amount Raised
$14 Million
Round Type
Series A
GuangzhouBiotechnologyHealth CareMedicalInvestors
Description
Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered in Guangzhou, China, has secured US $14 million (RM 100 million) in Series A funding from investors including Cherami Investment Group, Philips, JHF Investment, COCOCAPITAL Corporation, and Strategy Capital. The funding will enable the company to further develop its AI cancer treatment product portfolio and ecosystem. It will also accelerate the adoption of the company's AI-defined cancer surgery and radiotherapy workflow software and hardware products by hospitals and medical technology companies.
Quick answer
PVmed raised $14 Million in a Series A round, dated December 23, 2022. Investors: Strategy Capital, Cococapital Corporation, JHF Investment and Cherami Investment Group,. PVmed is based in Guangzhou, Guangdong, China.
- How much did PVmed raise?
- PVmed raised $14 Million in a Series A round on December 23, 2022.
- Who invested in PVmed?
- Strategy Capital, Cococapital Corporation, JHF Investment and Cherami Investment Group, are named as investors in this round.
- What does PVmed do?
- PVmed, pioneered in the field of medical technology, provides the state-of-art customized solutions to the healthcare industry.
- Where is PVmed based and how big is it?
- PVmed is based in Guangzhou, Guangdong, China.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as PVmed that raised within 45 days of this round, from Fundz verified event records.
- Incepto raised $3M (Seed) on February 3, 2023.
- INVO Fertility, Inc. raised $300K (Seed) on February 3, 2023.
- Stride raised $750K (Seed) on February 3, 2023.
- Streamex Corp. raised $2M (Seed) on February 3, 2023.
- Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
- HBM Alpha Therapeutics raised an undisclosed amount (Seed) on January 26, 2023.
Who to call at PVmed, and when
A new round usually means PVmed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PVmed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PVmed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PVmed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PVmed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansPVmed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.